Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business Highlights

Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) will release its financial results for Q1 2021 on May 10, 2021, prior to market opening. The results will be followed by a conference call at 9:00 a.m. ET to discuss financial outcomes and business highlights. Interested parties can join the call by dialing specific numbers or through a live webcast available on the company's website.

The replay will be accessible until May 16, 2021. Founded in 2007 and based in Cambridge, MA, Akebia focuses on developing therapeutics for kidney disease.

News Market Reaction – AKBA

+0.95%

+0.95% Session move

In the trading session that priced this news, AKBA gained 0.95%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the first quarter ended March 31, 2021, on Monday, May 10, 2021 before the opening of the financial markets.

Akebia will host a conference call at 9:00 a.m. Eastern Time on Monday, May 10, to discuss its first quarter financial results and recent business highlights. To listen to the conference call, please dial (877) 458-0977 (domestic) or (484) 653-6724 (international) using conference ID number 6250159. The call will also be webcast LIVE and can be accessed via the Investors section of the Company's website at http://ir.akebia.com.

A replay of the conference call will be available two hours after the completion of the call through May 16, 2021. To access the replay, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and reference conference ID number 6250159. An online archive of the conference call can be accessed via the Investors section of the Company's website at http://ir.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Investor Contact
Kristen K. Sheppard, Esq
ir@akebia.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-first-quarter-2021-financial-results-and-discuss-recent-business-highlights-301278435.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics release its Q1 2021 financial results?

Akebia Therapeutics will release its Q1 2021 financial results on May 10, 2021.

What time is the conference call for Akebia's Q1 financial results?

The conference call for Akebia's Q1 financial results is scheduled for 9:00 a.m. ET on May 10, 2021.

How can I access the replay of Akebia's conference call?

The replay of Akebia's conference call will be available until May 16, 2021, by dialing specific numbers or accessing it through their website.

What is the stock symbol for Akebia Therapeutics?

The stock symbol for Akebia Therapeutics is AKBA.